Kiribati vs Sweden: The number of people with susceptibility test result for rifampicin
Kiribati
177
in 2021
Sweden
173
in 2021
Kiribati rank
96th
Sweden rank
97th
The number of people with susceptibility test result for rifampicin over time
- Kiribati
- Sweden
How they compare
Kiribati currently reports 177 against 173 in Sweden, a difference of 4.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Sweden ahead.
Kiribati ranks 96th and Sweden ranks 97th of 155 countries.
Across the 2 decades both report, Kiribati averaged higher in 1 and Sweden in 1.
Head to head by decade
| Decade | Kiribati | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 115.67 | 255 | 139.33 | Sweden |
| 2020s | 175.5 | 171 | 4.5 | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kiribati or Sweden?
- Kiribati, at 177 against 173 in Sweden as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kiribati and Sweden?
- 4, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Kiribati and Sweden rank globally for the number of people with susceptibility test result for rifampicin?
- Kiribati ranks 96th and Sweden ranks 97th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.